Progress Toward Cardiac Xenotransplantation

Richard N. Pierson(Massachusetts General Hospital), Jay A. Fishman(Massachusetts General Hospital), Gregory D. Lewis(Massachusetts General Hospital), David A. D’Alessandro(Massachusetts General Hospital), Margaret R. Connolly(Massachusetts General Hospital), Lars Burdorf(Massachusetts General Hospital), Joren C. Madsen(Massachusetts General Hospital), Agnes M. Azimzadeh(Massachusetts General Hospital)
Circulation
October 5, 2020
Cited by 76Open Access
Full Text

Abstract

Consistent survival of life-supporting pig heart xenograft recipients beyond 90 days was recently reported using genetically modified pigs and a clinically applicable drug treatment regimen. If this remarkable achievement proves reproducible, published benchmarks for clinical translation of cardiac xenografts appear to be within reach. Key mechanistic insights are summarized here that informed recent pig design and therapeutic choices, which together appear likely to enable early clinical translation.


Related Papers

No related papers found

Powered by citation graph analysis